PURSUE WEALTH PARTNERS LLC

Position in CTMX — CytomX Therapeutics, Inc.

CIK 1911091 ALAMO, CA

Position in CTMX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$54,345

-$13,767 QoQ

Shares Held

14,492

0.0% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#146

of 178 holders

Holding Since

Jun 2025

5 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

PURSUE WEALTH PARTNERS LLC holds $1,312,865 across 4 Biotechnology names. CTMX ranks #4 (4.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	10,622	$577,943
2	ASND	Ascendis Pharma A/S	1,451	$387,010
3	VRTX	Vertex Pharmaceuticals Inc / Ma	591	$293,567
4	CTMX	CytomX Therapeutics, Inc. This page	14,492	$54,345

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$54,345	14,492	0.0%	Shares	Sole	2026-08-07
2026-03-31	$68,112	14,492	0.0%	Shares	Sole	2026-04-08
2025-12-31	$61,735	14,492	0.0%	Shares	Sole	2026-01-26
2025-09-30	$46,229	14,492	0.0%	Shares	Sole	2025-11-07
2025-06-30	$32,896	14,492	—	Shares	Sole	2025-08-13
No filing history on record for this holder in this stock.